SA PRO
Free Account
Insulet CorporationPODDNASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 90% recommend buying.

Consensus Rating
Buy
21 analysts·High coverage
90%
Rating Distribution
Strong Buy
00%
Buy
1990%
Hold
15%
Sell
15%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 48% higher.

Bear Case
$274.00
+7%
Consensus
$378.90
+48%
Bull Case
$450.00
+76%
Price Range21 analysts
Low
Consensus
High
$274.00
$450.00
Current Target
Current Price
$255.81
Upside to Target
$123.09

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 12, 2026Barclays
Insulet downgraded to Underweight from Equal Weight at Barclays
Target:$274.00
-4.5%from $286.92
Jan 9, 2026Bernstein
Insulet price target lowered to $380 from $410 at Bernstein
Target:$380.00
+29.7%from $292.89
Jan 9, 2026Goldman Sachs
Insulet price target lowered to $365 from $388 at Goldman Sachs
Target:$365.00
+24.6%from $292.89
Dec 18, 2025Truist Financial
Insulet price target lowered to $390 from $412 at Truist
Target:$390.00
+31.6%from $296.42
Dec 17, 2025Canaccord Genuity
Insulet price target raised to $450 from $432 at Canaccord
Target:$450.00
+55.9%from $288.73
Dec 16, 2025Evercore ISI
Insulet initiated with an Outperform at Evercore ISI
Target:$370.00
+25.3%from $295.31
Nov 24, 2025Canaccord Genuity
Insulet price target raised to $432 from $428 at Canaccord
Target:$432.00
+30.4%from $331.17
Nov 21, 2025Truist Financial
Insulet price target raised to $412 from $390 at Truist
Target:$412.00
+26.8%from $325.00
Nov 21, 2025RBC Capital
Insulet price target raised to $380 from $370 at RBC Capital
Target:$380.00
+17.2%from $324.19
Nov 21, 2025BTIG
Insulet price target raised to $380 from $370 at BTIG
Target:$380.00
+21.4%from $312.89
Nov 19, 2025UBS
Insulet upgraded to Buy from Neutral at UBS
Target:$400.00
+20.0%from $333.47
Nov 6, 2025Jefferies
Insulet Corporation (PODD) PT Raised to $400 at Jefferies
Target:$400.00
+23.7%from $323.40
Nov 6, 2025BTIG
BTIG Reiterates Buy Rating on Insulet Corporation (PODD)
Target:$370.00
+14.4%from $323.40
Nov 5, 2025Barclays
Insulet price target raised to $301 from $300 at Barclays
Target:$301.00
-6.0%from $320.27
Oct 10, 2025RBC Capital
Insulet price target raised to $365 from $350 at RBC Capital
Target:$365.00
+14.8%from $318.00
Sep 29, 2025Canaccord Genuity
Insulet price target raised to $399 from $353 at Canaccord
Target:$399.00
+25.5%from $318.00
Apr 28, 2025Wells Fargo
Wells Fargo sees new CEO appointment as 'significant positive' for Insulet
Target:$322.00
+24.1%from $259.52
Nov 8, 2024BTIG
Insulet Corporation (PODD) PT Raised to $270 at BTIG
Target:$270.00
+0.4%from $268.96
Nov 5, 2024Bernstein
Bernstein SocGen Group Starts Insulet Corporation (PODD) at Outperform
Target:$300.00
+24.3%from $241.32
Oct 14, 2024Raymond James
Insulet price target raised to $260 from $213 at Raymond James
Target:$260.00
+12.3%from $231.61
Sep 17, 2024Piper Sandler
Insulet price target raised to $285 from $230 at Piper Sandler
Target:$285.00
+21.9%from $233.89
Aug 27, 2024Piper Sandler
Piper Sandler Reiterates Overweight Rating on Insulet Corporation (PODD)
Target:$230.00
+18.9%from $193.51
Aug 27, 2024Oppenheimer
Oppenheimer Reiterates Outperform Rating on Insulet Corporation (PODD)
Target:$233.00
+20.4%from $193.54
Aug 27, 2024Jefferies
Jefferies Reiterates Buy Rating on Insulet Corporation (PODD)
Target:$260.00
+34.3%from $193.54
Aug 9, 2024BTIG
Insulet price target lowered to $250 from $270 at BTIG
Target:$250.00
+25.1%from $199.79

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance